Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 80.63M | $ 29.65M | $ 23.18M | $ 25.06M | $ 41.38M |
Total Assets | $ 516.90M | $ 465.79M | $ 421.36M | $ 462.66M | $ 430.72M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 306.79M | $ 260.21M | $ 217.50M | $ 250.29M | $ 214.71M |
Stockholders Equity | $ 210.12M | $ 206.48M | $ 204.45M | $ 212.82M | $ 216.44M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |